Some people may start to see results within a few weeks, while for others it may take a few months
These GLP-1 receptor agonists can be categorized as either short-acting compounds, which provide short-lived receptor activation (such as exenatide and lixisenatide) or as long-acting compounds (for example albiglutide, dulaglutide, exenatide long-acting release, and liraglutide), which activate the GLP-1 receptor continuously at their recommended dose
Surgical Risk: The use of GLP-1s can slow stomach emptying, which may pose risks (e.g., aspiration) during anesthesia if the medication is not paused prior to surgery
Its said to have an important effect on insulin responsiveness while also protecting against oxidative stress, support to increase in serotonin levels and maintain steady serum cortisol levels
Its also unclear if GLP-1 agonists are safe for pregnant or breastfeeding mothers